Zusammenfassung
Die HIV-Infektion ist eine durch das humane Immundefizienzvirus (HIV) hervorgerufene Krankheit, die seit Anfang der 80er-Jahre des vorigen Jahrhunderts bekannt ist, seit 1984 durch Antikörpertests diagnostiziert werden kann und seit 1996, als die modernen hochaktiven antiretroviralen Kombinationstherapien (HAART) eingeführt wurden, zu einer behandelbaren chronischen Erkrankung geworden ist. Seit 2005 bezeichnet man die Therapie als cART („combination antiretroviral therapy“). UN-AIDS veröffentlichte 2014 die Zielvorgabe, dass bis 2020 90 % aller HIV-Infektionen weltweit diagnostiziert und 90 % antiretroviral behandelt sein sollen, davon ebenfalls 90 % erfolgreich (Viruslast im Blut unterhalb der Nachweisgrenze), eine Forderung, die in Deutschland nahezu umgesetzt ist.
Literatur
Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69(18):1789–1799
Arendt G, Nolting T, Frisch C, Husstedt IW, Gregor N, Koutsilieri E, Maschke M, Angerer A, Obermann M, Neuen-Jacob E, Adams O, Loeffert S, Riederer P, ter Meulen V, Sopper S (2007) Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease. J Neurovirol 13(3):225–232
Arendt G, Schlonies S, Orhan E, Stüve O (2019) Simplification of combination antiretroviral therapy (cART) and the brain – a real life experience. J Neurovirol 25(2):174–182
Aziz-Donnelly A, Harrison TB (2017) Update of HIV-associated sensory neuropathies. Curr Treat Options Neurol 19(10):36
Brew BJ, Crowe SM, Landay A, Cysique LA, Guillemin G (2009) Neurodegeneration and ageing in the HAART era. J Neuroimmune Pharmacol 4(2):163–174
Cysique LA, Brew BJ (2019) Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm. J Neurovirol. https://doi.org/10.1007/s13365-018-0706-5. [Epub vor Druck]
Cysique L, Casaletto LB, Heaton RK (2019) Reliably measuring cognitive change in the era of chronic HIV infection and chronic HIV-associated neurocognitive disorders. Curr Top Behav Neurosci. https://doi.org/10.1007/7854_2019_116. [Epub vor Druck]
Dore GJ, Li Y, McDonald A, Ree H, Kaldor JM (2003) Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia. J Acquir Immune Defic Syndr 29(4):388–395
Goudsmit J, de Wolf F, Paul DA, Epstein LG, Lange JM, Krone WJ, Speelman H, Wolters EC, Van der Noordaa J, Oleske JM et al (1986) Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet 2(8500):177–180
Heywood W, Lyons A (2016) HIV and elevated mental health problems: diagnostic, treatment and risk patterns for symptoms of depression, anxiety and stress in a national community-based cohort of gay men living with HIV. AIDS Behav 20:1632–1645
Joint United Nations Programme on HIV/AIDS (2014) 90-90-90: an ambitious treatment target to help end the AIDS epidemic. UNAIDS, Geneva
Kaida K, Ariga T, Yu RK (2009) Antiganglioside antibodies and their pathophysiological effects on Guillain-Barre syndrome and related disorders – a review. Glycobiology 19(7):676–692
Kaku M, Simpson D (2018) Neuromuscular complications of HIV infection. Handb Clin Neurol 152:201–212
Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ, CHARTER Group (2008) Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65(1):65–70
Moodley K, Bill PL, Patel VB (2016) A comparative study of CIDP in a cohort of HIV-infected and HIV-uninfected patients. Neurol Neuroimmunol Neuroinflamm 4(2):e315
Murdoch DM, Suchard MS, Venter WD, Mhlangu P, Ottinger JS, Feldman C, Van Rie A, Glencross DK, Stevens WS, Weinhold KJ (2009) Polychromatic immunophenotypic characterization of T cell profiles among HIV-infected patients experiencing immune reconstitution inflammatory syndrome (IRIS). AIDS Res Ther 6:16
Prior DE, Song N, Cohen JA (2018) Neuromuscular diseases associated with human immunodeficiency virus infection. Neurol Sci 387:27–36
Sereti I, Sheikh V, Shaffler D, Phanupak N, Gabriel E, Warig J, Nason MC, Roby G, Ngeno H, Kirui F, Pau A, Mican JM, Rupert A, Bishop R, Agan B, Chomchey N, Teeratakulpisam N, Tansuphaswadiku S, Langat D, Kosgei J, French M, Ananworanich J, Sawe F, IRIS NIAID/IDCRP team (2019) Prospective international study of incidence and predictors if immune reconstitution inflammatory syndrome and death in people with HIV and severe lymphopenia. Clin Infect Dis. [Epub vor Druck]
Shelburne SA 3rd, Hamill RJ (2003) The immune reconstitution inflammatory syndrome. AIDS Rev 5(2):67–79
Sico JJ, Chang CC, So-Armah K, Justice AC, Hylek E, Skanderson M, McGinnis K, Kuller LH, Kraemer KL, Rimland D, Bidwell Goetz M, Butt AA, Rodriguez-Barradas MC, Gibert C, Leaf D, Brown ST, Samet J, Kazis L, Bryant K, Freiberg MS, Veterans Aging Cohort Study (2015) HIV status and the risk of ischemic stroke among men. Neurology 84:1933–1940
Smith DM, Zarate S, Shao H, Pillai SK, Letendre SL, Wong JK, Richman DD, Frost SD, Ellis RJ (2009) Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations. Virology 385(1):204–208
Verma A (2001) Epidemiology and clinical features of HIV-1 associated neuropathies. J Peripher Nerv Syst 6(1):8–13
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this entry
Cite this entry
Arendt, G. (2020). HIV-Infektion/AIDS: Neurologische Aspekte. In: Berlit, P. (eds) Klinische Neurologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44768-0_104-1
Download citation
DOI: https://doi.org/10.1007/978-3-662-44768-0_104-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-44768-0
Online ISBN: 978-3-662-44768-0
eBook Packages: Springer Referenz Medizin